Third-Grader In East Boston Tests Positive For Mumps
BOSTON (CBS) — A third-grader at Otis Elementary School in Boston has tested positive for the mumps, the school principal told parents Friday.
“We do not believe the student has come into close contact with any students in our school who are not vaccinated. It’s important to note that the mumps can only be transmitted from one person to another through close contact,” said a letter from Principal Paula Cerqueira-Goncalves.
According to policies by Boston Public Schools, Boston Public Health Commission, and Department of Public Health, all students are required to show documentation that they received th...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 27, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Seen On WBZ-TV Syndicated Local mumps Source Type: news
Outbreaks of Meningococcal Disease Caused by Serogroup B Outbreaks of Meningococcal Disease Caused by Serogroup B
A new report identifies outbreaks of meningococcal disease on university campuses and highlights the importance of MenB vaccination efforts among this population.Emerging Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 26, 2019 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news
Continuing PC vaccine in Kenya at full price cost-effective and could save thousands of lives
(London School of Hygiene& Tropical Medicine) Continuing the pneumococcal conjugate vaccine (PCV) in Kenya after the country transitions away from Gavi, the Vaccine Alliance, support is highly cost-effective and estimated to save thousands of children's lives, according to new research published in The Lancet Global Health. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 15, 2019 Category: Infectious Diseases Source Type: news
Africa: Humanitarian Mechanism for Vaccines Used for First Time in Europe to Counter High Prices
[MSF] M édecins Sans Frontières (MSF) has started vaccinating refugee children on the Greek islands of Chios, Samos and Lesvos using a programme set up to allow children in humanitarian emergencies to access the pneumococcal conjugate vaccine (PCV) at an affordable price. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 12, 2019 Category: African Health Source Type: news
Pneumovax 23 (Pneumococcal Vaccine Polyvalent) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 10, 2019 Category: Drugs & Pharmacology Source Type: news
Nigeria: NAFDAC Raises Alert On Fake Meningitis Vaccines
[Daily Trust] The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted the Nigerians, especially health care providers, on the circulation of a fake meningitis vaccines circulating in Niger Republic. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 4, 2019 Category: African Health Source Type: news
CDC: Flu Season May Not Have Peaked, Another Wave Of Severe Infections Underway
(CNN) — Flu activity remains high across the nation, and there’s a second wave of severe infections striking some states.
There were as many as 26.3 million flu illnesses, 12.4 million medical visits and 347,000 flu hospitalizations between October 1 and March 2, according to the weekly flu report released Friday by the US Centers for Disease Control and Prevention.
“We’re still having flu. And we’re still seeing a steady stream of patients who are being admitted to hospital with influenza,” said Dr. William Schaffner, medical director of the National Foundation for Infectious Diseases.
...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 8, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News CNN Flu Source Type: news
Pneumococcal Vaccination at Age 50 Prevents the Most Disease
MONDAY, March 4, 2019 -- Recommending pneumococcal vaccination for all 50-year-olds prevents the most disease in underserved minorities and the general population, but the cost exceeds $250,000 per quality-adjusted life-year (QALY) gained, according... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 4, 2019 Category: Pharmaceuticals Source Type: news
Reevaluating pneumococcal vaccine guidance: An analysis
(University of Pittsburgh) If mitigating racial disparities in those who contract pneumococcal diseases, such as meningitis and pneumonia, is a top public health priority, then recommending that all adults get a pneumococcal vaccine at age 50 would likely be effective guidance. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 4, 2019 Category: Infectious Diseases Source Type: news
Pneumococcal conjugate vaccines − cost effectiveness in Turkey
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - February 28, 2019 Category: Drugs & Pharmacology Source Type: news
Current US adult pneumococcal vaccination policies cost effective
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - February 28, 2019 Category: Drugs & Pharmacology Source Type: news
High Rates of MenB Vaccination Advised in University Outbreaks
THURSDAY, Feb. 14, 2019 -- Achieving high serogroup B meningococcal (MenB) vaccination coverage is recommended following university-based outbreaks of meningococcal disease caused by serogroup B, according to a study published online Feb. 13 in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 14, 2019 Category: Pharmaceuticals Source Type: news
Childhood Pneumonia Rates Low 7 Years After Pneumococcal Vaccine Implementation Childhood Pneumonia Rates Low 7 Years After Pneumococcal Vaccine Implementation
The incidence of community-acquired pneumonia (CAP) in children remains lower seven years after implementation of the 13-valent pneumococcal conjugate vaccine (PCV13), according to a study from eight French pediatric emergency departments.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 6, 2019 Category: Consumer Health News Tags: Medscape Today News Source Type: news
Gambia: Meningitis Vaccination Campaign Gets Underway
[Foroyaa] The2019 campaign against Meningitis A with Vitamin A supplementation and deworming, has commenced nationwide on Saturday February 3rd 2019. The campaign is meant to protect children against Meningitis, vitamin A deficiency and worm infestation. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 5, 2019 Category: African Health Source Type: news
Vaccination with Streptococcus mitis could protect against virulent sibling, Streptococcus pneumonia
(American Society for Microbiology) Vaccinating laboratory mice with Streptococcus mitis bacteria prevents their virulent sibling, Streptococcus pneumoniae from infecting the mice. The research suggests that vaccination of humans with live S. mitis might offer protection from some of the many serotypes of S. pneumoniae that vaccines currently do not exist for. This pathogen is one of the most common causes of severe pneumonia, and can also cause meningitis, bloodstream and sinus infections, endocarditis, and middle ear infections in young children. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 30, 2019 Category: International Medicine & Public Health Source Type: news
